Your browser doesn't support javascript.
loading
Dominantly inherited micro-satellite instable cancer - the four Lynch syndromes - an EHTG, PLSD position statement.
Møller, Pal; Seppälä, Toni T; Ahadova, Aysel; Crosbie, Emma J; Holinski-Feder, Elke; Scott, Rodney; Haupt, Saskia; Möslein, Gabriela; Winship, Ingrid; Broeke, Sanne W Bajwa-Ten; Kohut, Kelly E; Ryan, Neil; Bauerfeind, Peter; Thomas, Laura E; Evans, D Gareth; Aretz, Stefan; Sijmons, Rolf H; Half, Elizabeth; Heinimann, Karl; Horisberger, Karoline; Monahan, Kevin; Engel, Christoph; Cavestro, Giulia Martina; Fruscio, Robert; Abu-Freha, Naim; Zohar, Levi; Laghi, Luigi; Bertario, Lucio; Bonanni, Bernardo; Tibiletti, Maria Grazia; Lino-Silva, Leonardo S; Vaccaro, Carlos; Valle, Adriana Della; Rossi, Benedito Mauro; da Silva, Leandro Apolinário; de Oliveira Nascimento, Ivana Lucia; Rossi, Norma Teresa; Debniak, Tadeusz; Mecklin, Jukka-Pekka; Bernstein, Inge; Lindblom, Annika; Sunde, Lone; Nakken, Sigve; Heuveline, Vincent; Burn, John; Hovig, Eivind; Kloor, Matthias; Sampson, Julian R; Dominguez-Valentin, Mev.
Afiliação
  • Møller P; Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, PO Box 4950, 0424, NydalenOslo, Norway. moller.pal@gmail.com.
  • Seppälä TT; Faculty of Medicine and Health Technology, Cancer Centre, Tampere University and Tays, Tampere University Hospital, Tampere, Finland.
  • Ahadova A; Department of Gastrointestinal Surgery, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
  • Crosbie EJ; Applied Tumor Genomics, Research Program Unit, University of Helsinki, Helsinki, Finland.
  • Holinski-Feder E; Department of Applied Tumour Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Scott R; Clinical Operation Unit Applied Tumour Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Haupt S; Molecular Medicine Partnership Unit (MMPU), European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
  • Möslein G; Gynaecological Oncology Research Group, Manchester University NHS Foundation Trust, Manchester, UK.
  • Winship I; Division of Cancer Sciences, University of Manchester, Manchester, UK.
  • Broeke SWB; Medizinische Klinik Und Poliklinik IV, Klinikum Der Universität München, Campus Innenstadt, 80336, Munich, Germany.
  • Kohut KE; Center of Medical Genetics, 80335, Munich, Germany.
  • Ryan N; Hunter Medical Research Institute, University of Newcastle, New Lambton, NSW, 2305, Australia.
  • Bauerfeind P; Engineering Mathematics and Computing Lab (EMCL), Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University, Heidelberg, Germany.
  • Thomas LE; Data Mining and Uncertainty Quantification (DMQ), Heidelberg Institute for Theoretical Studies (HITS), Heidelberg, Germany.
  • Evans DG; Surgical Center for Hereditary Tumors, Academic Hospital University, Ev. Bethesda Khs Duisburg, Düsseldorf, Germany.
  • Aretz S; Genomic Medicine, The Royal Melbourne Hospital, Melbourne, Australia.
  • Sijmons RH; Department of Medicine, University of Melbourne, Melbourne, Australia.
  • Half E; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Heinimann K; Centre for Psychosocial Research in Cancer, Health Sciences, University of Southampton, Southampton, UK.
  • Horisberger K; Medical School, University of Edinburgh, Edinburgh, UK.
  • Monahan K; Department of Gynaecology Oncology, Royal Infirmary of Edinburgh, Edinburgh, UK.
  • Engel C; Hirslanden clinic, St.Anna Str. 36, 6006, Luzern, Switzerland.
  • Cavestro GM; Institute of Life Science, Swansea University, Swansea, SA28PP, UK.
  • Fruscio R; Manchester Centre for Genomic Medicine, Division of Evolution Infection and Genomic Sciences, University of Manchester, Manchester, M13 9WL, UK.
  • Abu-Freha N; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.
  • Zohar L; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, 53127, Bonn, Germany.
  • Laghi L; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Bertario L; Gastrointestinal Cancer Prevention Unit, Gastroenterology Department, Rambam Health Care Campus, Haifa, Israel.
  • Bonanni B; Medical Genetics, Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
  • Tibiletti MG; Department of General, Visceral and Transplatation Surgery, University Hospital of Mainz, Mainz, Germany.
  • Lino-Silva LS; Lynch Syndrome & Family Cancer Clinic, Centre for Familial Intestinal Cancer, St Mark's Hospital, London, HA1 3UJ, Harrow, UK.
  • Vaccaro C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, 04107, Leipzig, Germany.
  • Valle AD; Gastroenterology and Gastrointestinal Endoscopy Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, 20132, Milan, Italy.
  • Rossi BM; Clinic of Obstetrics and Gynecology, Department of Medicine and Surgery, University of Milan-Bicocca, Fondazione IRCCS San Gerardo, Monza, Italy.
  • da Silva LA; Soroka University Medical Center, Ben-Gurion University of the Negev, Beer Sheva, Israel.
  • de Oliveira Nascimento IL; Service High Risk GI Cancer Gastroenterology, Department Rabin Medical Center, Rabin, Israel.
  • Rossi NT; Laboratory of Molecular Gastroenterology, IRCCS Humanitas Research Hospital, Parma, Italy.
  • Debniak T; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Mecklin JP; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology, Fondazione IRCCS Instituto Nazionale dei Tumori, IRCCS, 20141, Milan, Italy.
  • Bernstein I; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141, Milan, Italy.
  • Lindblom A; Ospedale di Circolo ASST Settelaghi, Università dell'Insubria, Centro di Ricerca tumori eredo-familiari, Varese, Italy.
  • Sunde L; Surgical Pathology, Instituto Nacional de Cancerologia, Mexico City, Mexico.
  • Nakken S; Instituo Medicina Translacional e Ingenieria Biomedica - Hospital Italiano Bs As. - CONICET, Buenos Aires, Argentina.
  • Heuveline V; Hospital Central de las Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay.
  • Burn J; Hospital Sírio-Libanês, São Paulo, Brasil.
  • Hovig E; Hospital Universitário Oswaldo Cruz/Universidade de Pernambuco, Recife, Brazil.
  • Kloor M; Instituto de Ciência da Saúde da UFBA/NOB-Grupo Oncoclinicas, Salvador, Brazil.
  • Sampson JR; Fundación para el Progreso de la Medicina y Sanatorio Allende, Córdoba, Argentina.
  • Dominguez-Valentin M; Department of Genetics and Pathology, Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-252, Szczecin, Poland.
Hered Cancer Clin Pract ; 21(1): 19, 2023 Oct 11.
Article em En | MEDLINE | ID: mdl-37821984
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Hered Cancer Clin Pract Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Hered Cancer Clin Pract Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega